Anne-Marie Schott

Anne-Marie Schott

Auto-generated profile, based on publicly available information

Anne-Marie Schott

Université Claude Bernard Lyon 1, Lyon, France

Research Focus & Metrics

Academic Career Length

41Years (1986-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2007 in Osteoporosis International
Verified
Journal Article
Closed access
PDF file
JKJ. A. Kanis
J. A. Kanis
AOA. Oden
A. Oden
OJO. Johnell
O. Johnell
HJH. Johansson
H. Johansson
CLC. De Laet
C. De Laet
NYN. Yoshimura
N. Yoshimura

1 January 2019 in The Lancet Oncology
Verified
Journal Article
Closed access
OROlivier Rouvière
Olivier Rouvière
PPPhilippe Puech
Philippe Puech
RRRaphaële Renard-Penna
Raphaële Renard-Penna
MCMichel Claudon
Michel Claudon
CRCatherine Roy
Catherine Roy
JWJochen Walz
Jochen Walz

1 August 1996 in The Lancet
Verified
Journal Article
Closed access
DHD Hans
D Hans
PDP Dargent-Molina
P Dargent-Molina
ASAm Schott
Am Schott
JSJl Sebert
Jl Sebert
CCC Cormier
C Cormier
PMPj Meunier
Pj Meunier

1 July 1996 in The Lancet
Verified
Journal Article
Closed access
PDP Dargent-Molina
P Dargent-Molina
FFF Favier
F Favier
HGH Grandjean
H Grandjean
CBC Baudoin
C Baudoin
ASAm Schott
Am Schott
GBG Bréart
G Bréart

3 August 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
FDFrançoise Ducimetière
Françoise Ducimetière
ALAntoine Lurkin
Antoine Lurkin
DRDominique Ranchère-Vince
Dominique Ranchère-Vince
ADAnne-Valérie Decouvelaere
Anne-Valérie Decouvelaere
MPMichel Peoc'h
Michel Peoc'h
IRIsabelle Ray-Coquard
Isabelle Ray-Coquard
The exact overall incidence of sarcoma and sarcoma subtypes is not known. The objective of the present population-based study was to determine this incidence in a European region (Rhone-Alpes) of six million inhabitants, based on a central pathological review of the cases. From March 2005 to February 2007, pathology reports and tumor blocks were prospectively collected from the 158 pathologists of the Rhone-Alpes region. All diagnosed or suspected cases of sarcoma were collected, reviewed centrally, examined for molecular alterations and classified according to the 2002 World Health Organization classification. Of the 1287 patients screened during the study period, 748 met the criteria for inclusion in the study. The overall crude and world age-standardized incidence rates were respectively 6.2 and 4.8 per 100,000/year. Incidence rates for soft tissue, visceral and bone sarcomas were respectively 3.6, 2.0 and 0.6 per 100,000. The most frequent histological subtypes were gastrointestinal stromal tumor (18%; 1.1/100,000), unclassified sarcoma (16%; 1/100,000), liposarcoma (15%; 0.9/100,000) and leiomyosarcoma (11%; 0.7/100,000). The observed incidence of sarcomas was higher than expected. This study is the first detailed investigation of the crude incidence of histological and molecular subtypes of sarcomas.

1 January 2008 in Journal of Clinical Densitometry
Verified
Journal Article
Closed access
MKMarc-Antoine Krieg
Marc-Antoine Krieg
RBReinhart Barkmann
Reinhart Barkmann
SGStefano Gonnelli
Stefano Gonnelli
ASAlison Stewart
Alison Stewart
DBDouglas C. Bauer
Douglas C. Bauer
DHDidier Hans
Didier Hans